Practice
Featured experience
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Dunkin’ 2025-1 $900 million whole business securitization offering
We advised the initial purchasers on the offering
Inventiva $100 million at-the-market offering
The American depository shares are listed on Nasdaq
Ardelyx $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Bloom Energy $2.5 billion convertible senior notes offering
The 0% convertible senior notes are due 2030
Zenergy HK$504 million placement of shares
We advised Zenergy on the placement of new shares
Bank of America €2.75 billion senior notes offering
The investment-grade notes are due 2029 and 2031
Qnity Electronics $5.35 billion spinoff financings
The loan financing and notes offering were made in connection with the spinoff by DuPont de Nemours of Qnity Electronics
Oculis Holding $110 million concurrent stock offerings
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Cybin $175 million registered direct offering
The common shares are dual-listed on the NYSE American and Cboe Canada